Acarbose
- Product NDC
- 50090-4115
- 11-digit product format
- 500904115
- Labeler code
- 50090
- Product ID
- 50090-4115_6f276550-2026-450b-8f77-757048d5f5b8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- acarbose
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- NDA020482
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2008-01-30
- Marketing end
- 0000-00-00
- Substance
- ACARBOSE
- Active strength
- 50 mg/1
- Pharmacologic classes
- alpha Glucosidase Inhibitors [MoA],alpha-Glucosidase Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50090-4115-0 | Acarbose | 42 in 1 BOTTLE | TABLET | 42 | | 4 |
| 50090-4115-1 | Acarbose | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50090-4115 | ACARBOSE TABLET [A-S MEDICATION SOLUTIONS] | 4 | Legacy NDC, 2 package rows | 20190501_4cbedeb9-d270-4e2f-8cb7-f8a8dfa4a0db.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-4115-0 | 50090411500 | 42 TABLET in 1 BOTTLE (50090-4115-0) | 42 tablet | 2019-02-01 | 0000-00-00 | No | No | Current |
| 50090-4115-1 | 50090411501 | 30 TABLET in 1 BOTTLE, PLASTIC (50090-4115-1) | 30 tablet | 2014-11-28 | 0000-00-00 | No | No | Current |